help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 9, 2009
Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2009-0814
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
94/11/4391    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Solanas-Barca, M.
Right arrow Articles by Civeira, F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Solanas-Barca, M.
Right arrow Articles by Civeira, F.
Related Collections
Right arrow Lipid
Right arrow Metabolism

Submitted on April 15, 2009
Accepted on August 26, 2009

Mutations in HFE Causing Hemochromatosis Are Associated with Primary Hypertriglyceridemia

María Solanas-Barca, Rocío Mateo-Gallego, Pilar Calmarza, Estíbaliz Jarauta, Ana M. Bea, Ana Cenarro, and Fernando Civeira*

Unidad de Lípidos and Laboratorio de Investigación Molecular, Hospital Universitario Miguel Servet, Instituto Aragonés de Ciencias de la Salud (I+CS), 50009 Zaragoza, Spain

* To whom correspondence should be addressed. E-mail: civeira{at}unizar.es.

Context: Most cases of primary hypertriglyceridemia (HTG) are caused by the interaction of unknown polygenes and environmental factors. Elevated iron storage is associated with metabolic syndrome, diabetes, and obesity, and all of them are associated with HTG.

Objective: The aim of the study was to analyze whether HFE mutations causing hereditary hemochromatosis (HH) are associated with primary HTG.

Design: Genetic predisposition to HH was analyzed in a case-control study.

Setting: The study was conducted at University Hospital Lipid Clinic.

Participants: We studied two groups: 1) the HTG group, composed of 208 patients; and 2) the control group, composed of 215 normolipemic subjects and 161 familial hypercholesterolemia patients.

Intervention: Two HFE mutations (C282Y and H63D) were analyzed.

Main Outcome Measure: We measured HH genetic predisposition difference between groups.

Results: HH genetic predisposition was 5.9 and 4.4 times higher in the HTG group than in the normolipemic (P = 0.02) and FH (P = 0.05) subjects, respectively. There were 35 cases (16.8%) of iron overload in the primary HTG group, 14 (6.5%) and nine (5.6%) in the normolipidemic and FH groups, respectively. A higher HH genetic predisposition and a different prevalence of iron overload in subjects with HH genetic predisposition among groups contributed to this higher prevalence. None of the four cases with the HFE genotype associated with high risk of HH in the control groups presented iron overload; however, in eight of 11 subjects (72.7%) with primary HTG and HH genetic predisposition, the iron overload was present.

Conclusion: Mutations in HFE gene, favoring iron overload and causing HH, could play an important role in the development of several phenotypes of primary HTG.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society